S&P/ASX 200 Index (ASX: XJO) shares are 0.6% higher at 8.875.9 points on Thursday.
This week, brokers have reduced their ratings on several ASX 200 shares.
Let’s take a look.
Cochlear Ltd (ASX: COH)
The Cochlear share price is $110.20, down 1.7% today and down 65% over 12 months.
RBC Capital downgraded the ASX 200 healthcare share to a hold rating.
The broker reduced its 12-month price target from $125 to $117.
This implies a potential 6% upside ahead.
AMP Ltd (ASX: AMP)
The AMP share price is $2.15, up 0.7% today and up 29% over 12 months.
Jarden downgraded AMP shares to a hold rating, but increased its price target from $1.65 to $2.
This suggests a potential 7% downside ahead for the ASX 200 financial share.
Wesfarmers Ltd (ASX: WES)
The Wesfarmers share price is $88.76, down 1.3% today and up 6.8% over 12 months.
Morgan Stanley downgraded the ASX 200 consumer discretionary share to a sell rating today.
The broker lifted its 12-month price target slightly from $78.70 to $79.
This implies a potential 11% downside ahead.
Woolworths Group Ltd (ASX: WOW)
The Woolworths share price is $38.93, down 0.9% today and up 25% over 12 months.
JP Morgan downgraded the ASX 200 consumer staples share to a hold rating.
The broker raised its 12-month price target from $37 to $39.50.
This indicates a potential capital gain of just 1% over the next year.
Coles Group Ltd (ASX: COL)
The Coles share price is $23.50, up 0.4% today and up 16% over 12 months.
JP Morgan downgraded Coles shares to a hold rating with a $23.50 target.
This suggests the stock is fully valued at today’s price.
Flight Centre Travel Group Ltd (ASX: FLT)
The Flight Centre share price is $11.80, down 0.3% today and down 12% over 12 months.
Citi downgraded the ASX 200 travel share to a hold rating with a $13.20 target.
This suggests a potential 12% upside ahead.
Centuria Industrial REIT (ASX: CIP)
The Centuria Industrial REIT share price is $3.01, up 1.9% today and down 4% over 12 months.
Bell Potter downgraded the real estate investment trust (REIT) to a hold rating with a $3.25 target yesterday.
This suggests potential capital growth of 8% over the next year.
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix Pharmaceuticals share price is $14.95, up 0.6% today and down 30% over 12 months.
RBC Capital downgraded the ASX 200 tech share to a hold rating with an $18 target.
This still implies a healthy potential 20% upside ahead.
The post 8 ASX 200 shares downgraded by experts this week appeared first on The Motley Fool Australia.
Should you invest $1,000 in Amp right now?
Before you buy Amp shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Amp wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 16 June 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- How much could a $100,000 ASX share portfolio pay in dividends?
- How much does Morgan Stanley think Wesfarmers shares will fall?
- Canaccord Genuity picks its top 3 ASX industrial shares
- How many Cochlear shares do I need to buy for $10,000 of passive income?
- Are Telix shares a buy, hold or sell following results?
JPMorgan Chase is an advertising partner of Motley Fool Money. Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, JPMorgan Chase, Telix Pharmaceuticals, and Wesfarmers. The Motley Fool Australia has recommended Cochlear, Flight Centre Travel Group, Telix Pharmaceuticals, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.